Should I buy or sell Sera Prognostics stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sera Prognostics in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SERA shares. View SERA analyst ratings or view top-rated stocks .

What is Sera Prognostics' stock price target for 2024?

2 brokers have issued 12-month price targets for Sera Prognostics' stock. Their SERA share price targets range from $2.75 to $2.75. On average, they predict the company's stock price to reach $2.75 in the next twelve months. This suggests a possible upside of 45.5% from the stock's current price. View analysts price targets for SERA or view top-rated stocks among Wall Street analysts .

How have SERA shares performed in 2023?

Sera Prognostics' stock was trading at $1.26 at the beginning of 2023. Since then, SERA shares have increased by 50.0% and is now trading at $1.89. View the best growth stocks for 2023 here .

When is Sera Prognostics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 27th 2024. View our SERA earnings forecast .

How were Sera Prognostics' earnings last quarter?

Sera Prognostics, Inc. (NASDAQ:SERA) issued its quarterly earnings results on Tuesday, November, 9th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.22) by $0.17. The company earned $0.02 million during the quarter, compared to analyst estimates of $0.08 million. Sera Prognostics had a negative trailing twelve-month return on equity of 44.04% and a negative net margin of 11,534.24%.

When did Sera Prognostics IPO?

(SERA) raised $75 million in an IPO on Thursday, July 15th 2021. The company issued 4,687,500 shares at a price of $15.00-$17.00 per share.

Who are Sera Prognostics' major shareholders?

Sera Prognostics' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Sanders Morris Harris LLC (1.42%) and Sanders Morris Harris LLC (1.42%). Insiders that own company stock include Benjamin Jackson, John J Boniface and Robert Gardner Harrison. View institutional ownership trends .

How do I buy shares of Sera Prognostics?

Shares of SERA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Sera Prognostics Stock Price, News & Analysis (NASDAQ:SERA)

$1.89

-0.10 (-5.03%)

(As of 11/29/2023 ET)

Compare

Today's Range: $1.85
▼
$2.04
50-Day Range: $1.65
▼
$2.40
52-Week Range: $1.10
▼
$4.25

Volume: 9,846 shs
Average Volume: 395,323 shs
Market Capitalization: $59.23 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.75

Sera Prognostics MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 45.5% Upside
$2.75 Price Target
Short Interest: Healthy
1.84% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.16) to ($0.99) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.08 out of 5 stars

Medical Sector

458th out of 949 stocks

Medical Laboratories Industry

11th out of 22 stocks

3.3

Analyst's Opinion

Consensus Rating
Sera Prognostics has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $2.75, Sera Prognostics has a forecasted upside of 45.5% from its current price of $1.89.
Amount of Analyst Coverage
Sera Prognostics has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.84% of the float of Sera Prognostics has been sold short.
Short Interest Ratio / Days to Cover
Sera Prognostics has a short interest ratio ("days to cover") of 5.6.
Change versus previous month
Short interest in Sera Prognostics has recently decreased by 0.82%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Sera Prognostics does not currently pay a dividend.
Dividend Growth
Sera Prognostics does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SERA.

2.6

News and Social Media Coverage

News Sentiment
Sera Prognostics has a news sentiment score of 1.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Sera Prognostics this week, compared to 1 article on an average week.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sera Prognostics insiders have not sold or bought any company stock.
Percentage Held by Insiders
15.60% of the stock of Sera Prognostics is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 30.46% of the stock of Sera Prognostics is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Sera Prognostics are expected to grow in the coming year, from ($1.16) to ($0.99) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Sera Prognostics is -1.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Sera Prognostics is -1.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Sera Prognostics has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Sera Prognostics Stock (NASDAQ:SERA)

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

SERA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SERA Stock News Headlines

November 22, 2023 | finance.yahoo.com

SERA PROGNOSTICS TO PRESENT AT 35TH ANNUAL PIPER SANDLER HEALTHCARE CONFERENCE

November 12, 2023 | finance.yahoo.com

Sera Prognostics, Inc. (NASDAQ:SERA) Q3 2023 Earnings Call Transcript

November 29, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

November 12, 2023 | investing.com

Earnings call: Sera Prognostics Reports Q3 FY2023 Results, Focuses on Revenue Growth and Expense Management

November 9, 2023 | finanznachrichten.de

Sera Prognostics, Inc.: Sera Prognostics Reports Third Quarter 2023 Financial Results

November 8, 2023 | morningstar.com

Sera Prognostics Inc Class A SERA

November 8, 2023 | benzinga.com

Sera Prognostics: Q3 Earnings Insights

November 8, 2023 | msn.com

Sera Prognostics GAAP EPS of -$0.23 beats by $0.10, revenue of $0.04M

November 29, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

November 8, 2023 | finance.yahoo.com

Sera Prognostics Inc (SERA) Reports Q3 2023 Financial Results: Revenue Declines as Cost ...

November 8, 2023 | finance.yahoo.com

SERA PROGNOSTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS

October 25, 2023 | finance.yahoo.com

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2023 Financial Results on November 8, 2023

October 10, 2023 | msn.com

Why You Should Bet on These 5 Top-Ranked Stocks With Rising P/E

September 21, 2023 | finance.yahoo.com

SERA PROGNOSTICS TO PRESENT AT CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE 2023

August 31, 2023 | finance.yahoo.com

Sera Prognostics, Inc. (SERA) Loses -32.38% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

August 30, 2023 | finance.yahoo.com

Sera Prognostics, Inc. (SERA) Loses -38.49% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

August 16, 2023 | finanznachrichten.de

Sera Prognostics, Inc.: Sera Prognostics Reports Second Quarter 2023 Financial Results

August 11, 2023 | msn.com

Citigroup Maintains Sera Prognostics Inc (SERA) Neutral Recommendation

August 9, 2023 | finance.yahoo.com

SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS

August 9, 2023 | finance.yahoo.com

Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Tops Revenue Estimates

July 31, 2023 | finance.yahoo.com

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on August 9, 2023

June 28, 2023 | fool.com

Sera Prognostics (NASDAQ: SERA)

June 8, 2023 | msn.com

Sera Prognostics: Buy The PreTRM Moat

May 25, 2023 | marketwatch.com

Sera Prognostics Reduces Headcount to Cut Costs in Optimization Strategy

May 25, 2023 | finance.yahoo.com

Sera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and Revenue

May 15, 2023 | msn.com

Sera Prognostics CEO Critchfield to step down in June

May 15, 2023 | finance.yahoo.com

Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO

See More Headlines

Receive SERA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sera Prognostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/09/2021
Today: 11/29/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/27/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical laboratories
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SERA
CUSIP: N/A
CIK: 1534969
Web: www.seraprognostics.com
Phone: 801-990-0520
Fax: N/A
Employees: 87
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $2.75
High Stock Price Target: $2.75
Low Stock Price Target: $2.75
Potential Upside/Downside: +45.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.22)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-44,190,000.00
Net Margins: -11,534.24%
Pretax Margin: -11,534.24%
Return on Equity: -44.04%
Return on Assets: -37.26%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.51
Quick Ratio: 3.51

Sales & Book Value

Annual Sales: $270,000.00
Price / Sales: 219.38
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.41 per share
Price / Book: 0.78

Miscellaneous

Outstanding Shares: 31,340,000
Free Float: 26,448,000
Market Cap: $59.23 million
Optionable: Not Optionable
Beta: 0.29

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Ms. Evguenia Lindgardt M.B.A. (Age 49)
Interim President, CEO & Director
Comp: $37.5k
Dr. Gregory C. Critchfield M.D. (Age 70)
M.S., Executive Director
Comp: $790.74k
Dr. Steven W. Graves
Co-Founder and Co-Chairman of The Scientific Advisory Board
Dr. M. Sean Esplin M.D.
Co-Founder and Co-Chairman of Scientific Advisory Board
Mr. Austin Aerts
Chief Financial Officer??
Dr. John J. Boniface Ph.D. (Age 61)
Chief Scientific Officer
Comp: $386.69k
Mr. Robert G. Harrison (Age 57)
Chief Information Officer
Comp: $384.18k
Mr. Benjamin G. Jackson J.D. (Age 44)
General Counsel
Comp: $410.75k
Dr. Paul Kearney Ph.D. (Age 55)
Chief Data Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SERA Stock Analysis - Frequently Asked Questions

Should I buy or sell Sera Prognostics stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sera Prognostics in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SERA shares.
View SERA analyst ratings or view top-rated stocks.
What is Sera Prognostics' stock price target for 2024?: 2 brokers have issued 12-month price targets for Sera Prognostics' stock. Their SERA share price targets range from $2.75 to $2.75. On average, they predict the company's stock price to reach $2.75 in the next twelve months. This suggests a possible upside of 45.5% from the stock's current price.
View analysts price targets for SERA or view top-rated stocks among Wall Street analysts.
How have SERA shares performed in 2023?: Sera Prognostics' stock was trading at $1.26 at the beginning of 2023. Since then, SERA shares have increased by 50.0% and is now trading at $1.89.
View the best growth stocks for 2023 here.
When is Sera Prognostics' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 27th 2024.
View our SERA earnings forecast.

How were Sera Prognostics' earnings last quarter?: Sera Prognostics, Inc. (NASDAQ:SERA) issued its quarterly earnings results on Tuesday, November, 9th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.22) by $0.17. The company earned $0.02 million during the quarter, compared to analyst estimates of $0.08 million. Sera Prognostics had a negative trailing twelve-month return on equity of 44.04% and a negative net margin of 11,534.24%.
When did Sera Prognostics IPO?: (SERA) raised $75 million in an IPO on Thursday, July 15th 2021. The company issued 4,687,500 shares at a price of $15.00-$17.00 per share.
Who are Sera Prognostics' major shareholders?: Sera Prognostics' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Sanders Morris Harris LLC (1.42%) and Sanders Morris Harris LLC (1.42%). Insiders that own company stock include Benjamin Jackson, John J Boniface and Robert Gardner Harrison.
View institutional ownership trends.
How do I buy shares of Sera Prognostics?: Shares of SERA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SERA) was last updated on 11/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial